Ascendis Pharma and Novo Nordisk sign exclusive global license for TransCon technology, aiming to advance obesity, type 2 diabetes, and cardiovascular treatments.
Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug
Where Today's News Shapes Tomorrow
